SSRI withdrawal – a personal tale

I’ve just seen an article in yesterday’s New York Times magazine – Bruce Stutz has written his story of withdrawal from Effexor…

I think anyone who has gone through withdrawal and had a hard time doing it will identify immediately with much of the detail that Bruce has written – just as if he came upon this Blog he’d see he wasn’t alone.

In the recent past, patients who experienced these effects would simply be told to go back on their medication – told that their depression was returning… because of this so we simply do not know the true number of people who suffer because of their SSRI medication.

Self-Nonmedication can be read here.

Fabre-Kramer Refiles Gepirone ER with the FDA for the Treatment of Major Depressive Disorder

I said watch this space…

Tue, 08 May 2007 13:06:00 GMT

LONDON, PHILADELPHIA and HOUSTON — Fabre- Kramer Pharmaceuticals Inc. and GlaxoSmithKline announced today the submission by Fabre-Kramer to the Food and Drug Administration of an amendment to the New Drug Application for gepirone extended release (ER). The amendment responds to the FDA’s June 2004 request for an additional positive short term efficacy trial for gepirone ER.

Fabre-Kramer is seeking marketing approval of gepirone ER for the treatment of major depressive disorder. Fabre-Kramer and GlaxoSmithKline entered an agreement in February of this year for collaboration on the worldwide development and commercialization of gepirone ER.

I’ve already written about Gepirone ER here, here and here.

I wonder if anyone we know was involved in the research…. watch this space!